Blog
RIPA Buffer Recipe - Cell Lysis | Assay Genie
RIPA (Radio Immuno Precipitation Assay) buffer is mostly used when carrying out a western blot or immunoprecipatation assay. A RIPA buffer is used in order to lyse cells and extract protein from cultured cells. RIPA buffer cell lysis enables determination of protein concentration. RIPA buffer is an ideal cell lysis reagent since it contains three non-ionic and ionic detergents.
Preserving protein:protein interactions
When you need to preserve protein-protein interactions or to reduce denaturation its recommended to use a RIPA buffer recipe without SDS (ionic detergent) or Triton X-100 (non-ionic detergent).
RIPA buffer recipes
…
20th Aug 2021
Coeliac Disease Signaling – Review | Assay Genie
By Ciara Coleman PhD
General Introduction
Coeliac Disease (CD) is defined as a common, chronic inflammatory disease of the small intestine that occurs in genetically predisposed individuals and is triggered by exposure to the storage protein of wheat – gluten – and similar proteins in related grains (Schuppan et al., 2009). The word coeliac, meaning “hollow” in Greek, was first described by the Greek physician Aretaeus in the first century AD (Thomas, 1945). Although the first real description of Coeliac Disease came in 1888 by Samuel Gee (Gee, 1888), the link between Coeliac Disease and diet wasn’t esta
…
20th Aug 2021
Innate Viral Immunity & RIG-I in COVID-19
RIG-I: Antiviral Properties in COVID-19 (SARS-CoV-2) Infection
Key Points
RIG-I is a cytosolic RNA helicase which functions as a pattern recognition receptor (PRR) to detect double stranded RNA and other viral PAMPs.
RIG-I and RIG-I-like receptors are crucial for viral immunity and can activate a series of pro-inflammatory genes, creating a locally antiviral environment.
Contents
Structure
Function
Innate Immune Response
Conferring Viral Immunity
…
20th Aug 2021
Data Science for Immunologists | Assay Genie
By Dr. Niclas Thomas
“Data science” is a recent addition to the vocabulary of analytics, and can mean many different things to different people. As far as I am concerned, it is a fashionable term used to define the intersection of advanced analytical techniques from statistics, mathematics, machine learning and programming. The complexity of each of these fields can make them seem inaccessible to most biomedical researchers, who themselves have broad, complex fields of research to understand and may therefore have little time left to dedicate to emerging fields like data science. I started my career as a mathematician and took the bold step o
…
20th Aug 2021
Immuno-Biomaterial Development | Assay Genie
Background
I am a 3rd year PhD student in Trinity College Dublin and my project is very much an interdisciplinary one. I’m very lucky to get to work between two great labs, Dr. Aisling Dunne’s Molecular Immunology lab and Professor Danny Kelly’s Musculoskeletal engineering lab. My research focuses on osteoarthritis which involves damage to both the upper protective layer of cartilage and underlying bone. Unfortunately, the only real function restoring treatment option for patients is to undergo a total joint replacement surgery. However, the materials currently used in these orthopaedic implants are highly potent drivers of inflammation and often these implants loosen and fail due
…
20th Aug 2021
microbiota & immune system signaling | Assay Genie
You are only part human.
In some ways, you are as much bacteria as you are mammal, and in some ways bacteria make up far more of you than your own familiar cells and genes!
It is becoming increasingly apparent that the microbes that live inside you, in your gut and on your skin, have a large bearing on how likely you are to become ill, how much weight you carry and even your day-to-day mood. These effects are a result of communication between these microbes and the cells that live in close contact with them, a series of interactive processes we are just beginning to understand. A huge proportion of your microbial passengers live in your gut, and it is here that a vital interactio
…
20th Aug 2021
Acute Lymphoblastic Leukaemia Review | Assay Genie
Incidence rate of Acute Lymphoblastic Leukaemia
Acute lymphoblastic leukaemia (ALL) is one of the most common malignant diseases diagnosed in children. It represents nearly one third of all paediatric cancers and 74% of leukaemic disease in children from age 0-19 years. In 2010 the American Society of Cancer (ACS) predicted that 5,330 new cases of ALL would be detected and that 1,420 of these cases would result in death [Society, 2010].
Causes of ALL
The cause of ALL remains largely unknown, although potential risk factors include environmental factors, inherited genetic mutations and viral exposure, howev
…
20th Aug 2021
Filarial Infections - Tropical Diseases | Assay Genie
By Juan Quintana, PhD student, University of Edinbrugh
What are Neglected Tropical Diseases (NTDs)?
The World Health Organization (WHO) defines NTDs as a group of communicable, poverty-promoting diseases, which affect more than one billion people worldwide (Herricks et al., 2017). These diseases are primarily concentrated in sub-Saharan Africa, as well as in regions of South America and Asia (Herricks et al., 2017). The stigma surrounding these diseases, and their impact on children and women’s health, and worker productivity, are all factors that negatively contribute to the economic burden in these countries (Tur
…
20th Aug 2021
The common characteristics of cancer | Assay Genie
By Shane Houston, PhD Candidate Queen’s University Belfast
Cancer is an age old adversary of the human race. This out-of-control growth of abnormal cells has been a shadow over human health throughout history. Some of the earliest evidence of cancer stretches back to Egypt and the time of the pharaohs [1].
As time has marched on, so has our understanding of the disease, a field which came to be known as Oncology [1]. Early attempts at treating the disease most often involved surgical removal, followed by the hope the disease would not return [1]. Invariably it did. The current trend of research in cancer therapy is now leaning towards personalized medicine, a treatment approach bas
…
20th Aug 2021
Preeclampsia & immune cell regulation | Assay Genie
What is preeclampsia?
According to the World Health Organization (WHO), one in ten pregnant women is affected by hypertensive disorders, and preeclampsia alone accounts for one in seven maternal deaths (1). Preeclampsia is defined as a hypertensive disorder that can complicate pregnancy after 20 weeks of gestation although it is debatable whether critical pro-inflammatory and oxidative stress responses are triggered in certain individuals nearly after conception. If the condition is progressive or left unattended, it can be further complicated by neurological dysregulations, a condition known as eclampsia.
Preeclampsia cla
…
19th Aug 2021
Cells of the Immune System | Assay Genie
The Immune System
The immune system is a host defence system comprising many biological structures and processes within an organism that protects against disease. In order to function well, the immune system must detect a wide variety of agents, known as pathogens which can range from viruses to parasitic worms, and must have the ability to distinguish them from the host's healthy tissue. In most species the immune system consists of an innate and an adaptive immune response.
The innate immune response is stimulated when a pathogen successfully enters the host. It is the first line of defence and is required for the elimination of t
…
19th Aug 2021
Hydroxychloroquine: Potential Treatment for COVID-19
Hydroxychloroquine: Potential Treatment for COVID-19
What is Hydroxychloroquine?
Hydroxychloroquine (HCQ) belongs a family of medicines called antimalarials, which are also classified as disease-modifying anti-rheumatic agents, or DMARDs. Hydroxychloroquine was previously used to prevent and cure malaria. However, it has also been recognised to treat various other diseases such as rheumatoid arthritis, sarcoidosis (inflammatory disease of the lungs and lymph glands), lupus and Sjogren's syndrome whereby the white blood cells of the body affect the tear and saliva glands, thereby, reducing the amo
…
19th Aug 2021
What I learnt from meeting 1000+ researchers
Over the
past few years I have traversed through academia in a few different guises,
first as a PhD student for about 5 years, then onto the traditional route of a
post-doc, followed by a sales representative for a life sciences company and
finally as the co-founder of ELISA Genie. It’s been a great journey and I’m
constantly learning as I move through different facets of working with academics.Currently
I’m in year 3 of running my own scientific start-up, it’s a blast, I travel the
world, work on new projects every week, attend conferences, but the most
interesting part is where we help people with their research. To take a
few steps back, I was extremely chatty during my PhD, having
…
15th Mar 2021
Cell Signalling – Mini Review
Cell Signalling
Cell signalling pathways have an important role in integrating a plethora of extracellular and intracellular signals to produce a controlled optimal output of signals, and results in the regulation of specific cellular responses. This is crucial for the homeostasis of the cell, and the deregulation of signalling pathways has been related to a number of diseases including cancer (Choudhary and Mann 2010).
Receptor signalling
Cells integrate signals from the extracellular matrix by expressing specific receptors on the plasma membrane that can be activated by a specific ligand. Receptors then transduce the ex
…
15th Mar 2021
How to be a Confident Speaker (Scientific)
Like needles in a haystack, interesting speakers that bring charisma and rock n roll to their talks are hard to come by. No matter what the research interests of the audience, these speakers hypnotize the audience with their funny analogies and the confidence in their data. Leaving the audience inspired to run back to the lab, read more papers, carry on into post-docing or become a PI. Below I discuss how to be a confident speaker.
Preparing scientific talks
For these speakers, research can appear stress-free, with negative data some of their most interesting slides, and when they have no answers for their data, they blame serendipity on how they make so
…
15th Mar 2021
How to improve your relationship with your PI or Professor
After probably a round or two of interviews and a PhD in your pocket you would think that proving yourself in your new lab would not be an issue. After all, they did hire you because you were the best candidate for the position and you published some seminal papers on the topic in the months prior.
However, from day one as a new post-doc in a lab you have something to prove. Whether it’s getting the first experiment right or it’s presenting at your first lab meeting, not making an initial good impression in the lab can lead to some painful experimental scrutiny and hardship in the months to come. It might not help that you have just inherited a project from the previous post-doc that
…
15th Mar 2021
Keep your Lab Book up to Date
When PhDs and Post-Docs start in new lab they have the best intentions to keep their lab books up to date with notes, new research methods, data, and protocol information. These best efforts usually last for about a week, or for as long as they can see their professor walking about the lab. However, sooner or later diligence is lost and maintaining up to date notes on research methods and protocols happens once every blue moon.
Suddenly, stacks of western blots and PCR print-outs build up in drawers, lab books and lab benches, with barely legible labels, saved only by the dates from the PCR print-offs. Eventually, a random inspection from your professor or a looming lab meeting inspir
…
15th Mar 2021
Christmas Lab Party Competition | Assay Genie
We know it gets tiring being in the lab every day, especially with the evenings getting darker and gloomier. So, to get you in the festive spirit, we're holding a competition to win money to throw a Christmas lab party!
We have two prizes - one of €300 and another of €150.
All you have to do to enter is write us an 800 word blog post on one of the following topics:
Cell metabolism
Immunology
Signalling
Cancer research
The submissions will be posted on our site with credit.
Some examples of previous submissions can be found here:
Auto-inflammatory diseases and genetics
Chemokines and Chemokine Receptors
NLR inflammasomes, the enigmatic drivers of Inflammation
Entries can be sent to
…
15th Mar 2021
Bullying in the Laboratory and workplace
The lab can be one of the greatest places in the world to make live long friends. Spending countless hours in a tissue culture room late into the middle of the night, sharing similar frustrations when experiments don’t work or talking about how your PI does not have a clue what they are talking about can really bring people together. This is also compounded by the fact that you will spend some of the most formative years of your life with these people. They’ll be the first people you see in the morning, the last people you see at night, and the people that you will spend most of your time socializing outside of the lab with, bullying in the Laboratory and workplace can however change
…
15th Mar 2021
Microcalcifications in breast cancer: Novel insights into the molecular mechanism and functional consequences
Shane O’Grady, PhD student, RCSI
Cancer is a disease that will, unfortunately, touch all of our lives at some point, directly or indirectly. Despite decades of gradual, hard-won incremental improvements to available treatment options, survival is still strongly associated with the stage at which a tumour is first detected: patients diagnosed with stage 4 breast cancer have a 5 year survival rate approximately 4 times lower than those presenting in the clinic with a stage 1 tumour [1]. The ability to detect breast cancer at an early, more easily treated stage has been a significant contributor to improved survival rates observed in recent decades. Th
…
15th Mar 2021
Auto-inflammatory diseases and genetics (SAIDs)
Shelly Pathak PhD candidate, University of Leeds
SAIDs
Systemic Auto-inflammatory diseases (SAIDs) have been defined as a group of mainly inherited disorders due to ‘abnormal hyper activation of the innate immune system’ (1). These conditions lack the characteristic features of an adaptive immune response, such as high titre antibodies or antigen specific T cells, usually seen in classical autoimmune diseases (2). Periodic Fever Syndromes (PFS) are a branch of conditions encompassed within SAIDs and form the generally more well-known and characterised conditions.
Periodic Fever Syndromes
It was 1997 when the term ‘auto-inflammatory disease’ was f
…
15th Mar 2021
How does Acute Myeloid Leukaemia start?
I have been in the situation that I’m sure many of us have. I work on genes, which if you name to any right-minded individual, sound like a random string of nonsensical gibberish. So, maybe unsurprisingly, I have very little interest in writing a blog piece only about the particular genes I work on, so let’s look at AML in a wider context (and then maybe I’ll sneak in my research later).
Acute myeloid leukaemia (or AML as it is more commonly known), is the most common form of acute leukaemia in adults (Eriksson et al. 2015). This disease involves the uncontrolled accumulation of progenitors, that give rise to myeloid-type white blood cells, within the bone marrow. The accumulati
…
15th Mar 2021
Can infection cause chronic disease?
By Anusha Senevirante, Post-Doctoral researcher, Imperial College London
With non-communicable diseases (or NCDs, which include heart disease, diabetes, cancer) now responsible for the most deaths worldwide, large investments into research on these diseases are helping us understand their causes. Many of these diseases have something in common, they involve chronic inflammation. Cells normally triggered by the immune system to fight infection, are persistently activated by endogenous factors within the body, eventually causing damage to bodily tissues and beginning the disease processes involved in the development of diabetes, cancer and atheroscl
…
15th Mar 2021
Platinum based cancer drugs and next generation therapeutics
Platinum based cancer drugs
Despite nearly 50% of all
anti-cancer treatments being platinum-based, there is an urgent need to develop
novel therapeutics beyond those currently in use.1 The first platinum-based anti-cancer
chemotherapeutic, cisplatin, was granted clinical approval in 1978. Only two
further platinum drugs have gained full global approval namely carboplatin and
oxaliplatin.2 Although hugely successful, the widespread application
and efficacy of platinum drugs are hindered by their toxic side effects, their
limited activity against many human cancers and their susceptibility to
acquired drug resistance.3 As a consequence, many
…
15th Mar 2021